Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer

por O’Shea, Anne E., Clifton, Guy T., Peoples, George E.
Publicado 2021

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination

por Adams, Alexandra M., Vreeland, Timothy J., Clifton, Guy T., Peoples, George E.
Publicado 2021

Towards a consensus definition of immune exclusion in cancer

por Tiwari, Ankur, Oravecz, Tamas, Dillon, Laura A., Italiano, Antoine, Audoly, Laurent, Fridman, Wolf Hervé, Clifton, Guy Travis
Publicado 2023

Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury

por Hergenroeder, Georgene W, Moore, Anthony N, McCoy, J Philip, Samsel, Leigh, Ward, Norman H, Clifton, Guy L, Dash, Pramod K
Publicado 2010

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

por Greene, Julia, Schneble, Erika, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, McGuire, William, Maxwell, George, Ponniah, Sathibalan, Peoples, George
Publicado 2014

Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic

por Chick, Robert Connor, Clifton, Guy Travis, Peace, Kaitlin M., Propper, Brandon W., Hale, Diane F., Alseidi, Adnan A., Vreeland, Timothy J.
Publicado 2020

Maximizing Benefit of Virtual Learning: Lessons From the Coronavirus Disease 2019 Pandemic

por Carpenter, Elizabeth L., Adams, Alexandra M., Chick, Robert C., Stull, Mamie C., Hale, Diane F., Propper, Brandon W., Clifton, Guy T., Vreeland, Timothy J.
Publicado 2022

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

por Berry, John S, Schneble, Erika J, Trappey, Alfred F, Vreeland, Timothy J, Clifton, Guy T, Hale, Diane F, Sears, Alan K, Ponniah, Sathibalan, Mittendorf, Elizabeth A, Peoples, George E
Publicado 2013

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

por Jackson, Doreen, Qiao, Na, Greene, Julia M, Hale, Diane, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, Ibrahim, Nuhad, Toms, Annie, Peoples, George E, Mittendorf, Elizabeth A
Publicado 2015

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation

por Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Pattyn, Adam R, Clifton, Guy T, Berry, Elizabeth A, Schneble, Erika J, Kirkpatrick, Aaron D, Saenger, Jeffrey S, Peoples, George E
Publicado 2016

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine

por Greene, Julia, Schneble, Erika, Martin, Jonathan, Flores, Maddie, Trappey, Alfred, Berry, John, Vreeland, Timothy, Hale, Diane, Clifton, Guy, Perez, Sonia A, Papamichail, Michael, Peoples, George, Mittendorf, Elizabeth, Ponniah, Sathibalan
Publicado 2014

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients

por Schneble, Erika J, Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Hale, Diane F, Sears, Alan K, Clifton, Guy T, Ponniah, Sathibalan, Shumway, Nathan M, Mittendorf, Elizabeth A, Peoples, George E
Publicado 2013

Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes

por Vreeland, Timothy J, Berry IV, John S, Schneble, Erika, Jackson, Doreen O, Herbert, Garth S, Hale, Diane F, Martin, Jonathon M, Flores, Madeline, Pattyn, Adam R, Hata, Kai, Clifton, Guy T, Kirkpatrick, Aaron D, Peoples, George E.
Publicado 2017

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement

por Kemp Bohan, Phillip M., Chick, Robert C., Hickerson, Annelies T., Messersmith, Lynn M., Williams, Grant M., Cindass, Jessica L., Lombardo, Jamie, Collins, Ryan, Brady, Robert O., Hale, Diane F., Peoples, George E., Vreeland, Timothy J., Clifton, Guy T.
Publicado 2020

Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma

por McCarthy, Patrick M, Rendo, Matthew J, Uy, Matthew D, Adams, Alexandra M, O’Shea, Anne E, Nelson, Daniel William, Fenderson, Joshua L, Cebe, Katherine M, Krell, Robert W, Clifton, Guy T, Peoples, George E, Vreeland, Timothy J
Publicado 2021

Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop

por Clifton, Guy Travis, Rothenberg, Mace, Ascierto, Paolo Antonio, Begley, Glenn, Cecchini, Michael, Eder, Joseph Paul, Ghiringhelli, Francois, Italiano, Antoine, Kochetkova, Marina, Li, Rong, Mechta-Grigoriou, Fatima, Pai, Sara I, Provenzano, Paolo, Puré, Ellen, Ribas, Antoni, Schalper, Kurt A, Fridman, Wolf Herve
Publicado 2023

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

por McCarthy, Patrick M., Valdera, Franklin A., Smolinsky, Todd R., Adams, Alexandra M., O’Shea, Anne E., Thomas, Katryna K., Van Decar, Spencer, Carpenter, Elizabeth L., Tiwari, Ankur, Myers, John W., Hale, Diane F., Vreeland, Timothy J., Peoples, George E., Stojadinovic, Alex, Clifton, Guy T.
Publicado 2023

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients

por Brown, Tommy A., Byrd, Kevin, Vreeland, Timothy J., Clifton, Guy T., Jackson, Doreen O., Hale, Diane F., Herbert, Garth S., Myers, John W., Greene, Julia M., Berry, John S., Martin, Jonathan, Elkas, John C., Conrads, Thomas P., Darcy, Kathleen M., Hamilton, Chad A., Maxwel, George L., Peoples, George E.
Publicado 2019

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

por Vreeland, Timothy J., Clifton, Guy T., Hale, Diane F., Chick, Robert C., Hickerson, Annelies T., Cindass, Jessica L., Adams, Alexandra M., Bohan, Phillip M. Kemp, Andtbacka, Robert H. I., Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Terando, Alicia M., Wagner, Thomas, Peoples, George E., Faries, Mark B.
Publicado 2021

SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital — New York City, April 2020

por Clifton, Guy T., Pati, Rituparna, Krammer, Florian, Laing, Eric D., Broder, Christopher C., Mendu, Damodara R., Simons, Mark P., Chen, Hua-Wei, Sugiharto, Victor A., Kang, Anthony D, Stadlbauer, Daniel, Pratt, Kathleen P., Bandera, Bradley C., Fritz, Darron K., Millar, Eugene V., Burgess, Timothy H., Chung, Kevin K.
Publicado 2021